BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price
NASDAQ: BCTXL | Micro CapBriaCell Therapeutics Corp. Warrant expiring 2031 Stock Performance
BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price Today
As of 30 October 2026, BriaCell Therapeutics Corp. Warrant expiring 2031's share price is $0.90. The stock opened at $0.90, compared to its previous close of $0.90. During today's trading session, BriaCell Therapeutics Corp. Warrant expiring 2031's share price traded between $0.90 and $0.90, with an average price of $0.90. Over the past 52 weeks, the stock has recorded a high of $1.34 and a low of $0.65. In terms of performance, BriaCell Therapeutics Corp. Warrant expiring 2031's share price has declined by 12.62% over the last six months and is down 23.08% on a year-on-year basis.
BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price Chart
BriaCell Therapeutics Corp. Warrant expiring 2031 Quarterly Profit & Loss
All figures in USD
About BriaCell Therapeutics Corp. Warrant expiring 2031
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
BriaCell Therapeutics Corp. Warrant expiring 2031 Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.21 | $0.90 | -24.37% |
Sep 2026 | $0.97 | $1.19 | +38.37% |
Jul 2026 | $0.89 | $0.86 | +32.31% |
Jun 2026 | $0.83 | $0.65 | -31.58% |
May 2026 | $0.80 | $0.95 | -1.04% |
Apr 2026 | $1.05 | $0.96 | -6.80% |
Mar 2026 | $0.99 | $1.03 | +4.04% |
Feb 2026 | $1.11 | $0.99 | -15.38% |
Jan 2026 | $0.84 | $1.17 | N/A |